肝硬化肝性胸水20例临床分析  

作　　者：陈潇迪[1] 夏徵[1] 

机构地区：[1]四川省武警总队医院消化内科,614000

出　　处：《当代医学》2010年第4期51-52,共2页Contemporary Medicine

摘　　要：目的了解肝性胸水的临床表现、发病机制及治疗。方法收集本院2005年～2008年间20例肝性胸水患者的临床资料进行分析。结果本组20例病人临床症状主要表现为:呼吸困难、胸闷、咳嗽。胸水位于右侧占75%,双侧占15%,左侧占10%。经综合治疗,20例中有15例胸水完全消退,4例胸水明显减少,1例死亡(不配合治疗)。结论肝性胸水的临床表现取决于胸水形成的速度及量、患者耐受程度等多方面因素,其预后取决于肝硬化失代偿的严重程度、并发症的有无及轻重等,肝性胸水右侧居多,双侧次之,左侧最小,故对于肝性胸水患者提倡早诊断、综合治疗除应保肝外,还可采用治疗性胸腔穿刺术及向胸腔内注射抗生素等方法。Objective To understand the Hepatic hydrothorax clinical manifestation, pathogenesis and treatment. Methods We collected from 2005 to 2008 our 20 cases of patients with hepatic hydrothorax clinical data were analyzed. Results Clinical symptoms of 20 patients, difficulty breathing, bosom frowsty, cough. In the chest level 75 percent, bilateral 15%, left 10%. The comprehensive treatment, 20 cases have 12 cases of pleural effusion completely faded, 4 cases hydrothorax significantly reduced, and 1 died （with）. Conclusion Hepatic hydrothorax clinical manifestations depending on the speed of formation water chest pain tolerance and quantity, patients, the prognosis depends on the severity of the decompensated cirrhosis and complications can have heavy, hepatic hydrothorax, bilateral right, left the minimum, for patients with hepatic hydrothorax early diagnosis and treatment advocated in protecting liver, still can use therapeutic technic and chest to intrathoracic given antibiotics, etc.

关 键 词：肝性胸水 胸腔穿刺 治疗 发病机制 

分 类 号：R575.2[医药卫生—消化系统] R561.3[医药卫生—内科学]